- Research Article
109
- 10.1136/bmj.1.5441.1034
Myopathy in Metabolic Bone Disease
- Apr 17, 1965
- BMJ
- J W Prineas + 2 more +2
Intestinal Malabsorption-Rose BRIui not determined, but there was no haematological evidence of folic-acid deficiency. Kershaw and Girdwood (1964) found two out of six patients with disseminated carcinoma to have low serum folic-acid levels and increased Figlu excretions, and Girdwood (1953b) has reported evidence of folic-acid deficiency in this condition. The most likely explanation for such cases is that there is an increased demand for folic acid due to the proliferation of malignant cells. Dymock (1964a) has estimated the urinary excretion of urocanic acid and Figlu in 28 patients with malignant disease, and in 24 the outputs were abnormal. He did not measure the serum folic-acid levels, and in 10 cases there was some evidence of liver dysfunction (Dymock, 1964b). It is possible, therefore, that in some cases of disseminated malignancy the abnormal Figlu excretion results from an impairment of hepatic Figlu transferase activity.
Read more